Therabody bought Embr’s IP. Who handles an existing Wave 2?
If you already own a Wave 2, keep contacting Embr Labs for orders and product support. Therabody announced that it acquired Embr’s intellectual property portfolio, not that it took over every customer obligation. The wristband predates the deal. If you are considering a purchase, check the seller, support contact and written warranty for that specific offer. The announcement does not set a launch date for a new Therabody product or establish a change in warranty terms.
The Signal in brief
- What changed
Therabody announced on 18 November at 09:00 US Eastern time (22:00 Singapore time) that it had acquired Embr Labs’ intellectual property portfolio. The buyer explicitly directed Wave 2 owners to keep contacting Embr for orders and product support. This dates the announcement, not the signing or the transfer of any individual warranty.
- Why it matters
The name on a technology deal is not necessarily the name on your receipt. If your existing band has an order or product issue, going straight to the support team named by the buyer can avoid a wasted enquiry. It does not guarantee the answer will be a replacement or refund.
- Who it affects
Existing Wave 2 owners, people considering a purchase and retailers fielding questions about the transaction. The buyer’s direction expressly names Wave 2, not every previous model.
- Where
United States announcement; check exact seller, model, contract and country.
- What to watch
Check current Embr instructions when opening a case. Watch separately for a written change in support arrangements, a model-specific warranty notice or an orderable Therabody product listing. Each answers a different question.
- Who acquired the IP portfolio?Therabody, per its announcement
- Who handles Wave 2 support enquiries?Continue to contact Embr Labs
- Did a particular warranty transfer?No transfer document reviewed
- Can I buy a newly announced device?The buyer did not announce a dated new product listing
- Therabody, 18 Nov 2026 · 2026-11-18
Purchase price, detailed transfer documents, a future model or launch date, and changes to particular sellers’ obligations are not established. No clinical or performance judgment is made.
Explore this signal
Emerging data
A customer who bought Wave 2 from a shop and another who obtained one by subscription may both wear the same device. Their paperwork can tell different stories. Embr announced retail distribution partnerships in 2023 and a subscription offer in 2024. Those are reasons to check the original arrangement, not proof the old offers are still open. If Therabody develops this portfolio into a new device, the first useful buying signal will be a dated, orderable listing with a named seller, market and written support terms. The acquisition alone does not establish any of those.
The connection
IP can give a buyer rights to develop technology without moving every customer relationship. MIT documented the original wristband in 2017; Embr announced Wave 2 in 2021. Neither product began with this deal. In May 2026 Embr also announced public developer tools for Wave 2. That identifies a pre-existing software element, not a promise of future app support.
- 2017-09-27MIT reports on original wristband
- 2021-04-14Embr announces Wave 2
- 2026-11-18Therabody announces IP acquisition, not a new device
- MIT News, 27 Sep 2017 · 2017-09-27
- Embr Labs, 14 Apr 2021 · 2021-04-14
- Therabody, 18 Nov 2026 · 2026-11-18
The opportunity
For an existing Wave 2, find your original order confirmation and contact Embr Labs through its official support form. Keep the model, seller, order reference and applicable written terms. If buying now, identify the seller and country and read the terms for that offer before paying. For a gift, reseller order, subscription or first-generation band, ask about that exact arrangement.
If support asks which item you have, the 2021 manual identifies E100 and E101 as Wave 2 device models; E151 and E152 refer to chargers. Quote the label on the affected item. An old manual is not proof that its warranty period applies to your purchase now.
- 1Shopping now? Check exact offer, model, territory and written terms
- 2Already own Wave 2? Identify the seller on your receipt and contact Embr Labs
- 3Different generation or subscription? Ask about that arrangement
- 4New official instructions? Follow them for the model and market they cover
What could happen next
- First-order consequence
Existing Wave 2 customers have a named first contact. The buyer does not say they should move their order enquiry to Therabody.
- Second-order consequence
A seller may receive questions about which terms still apply. A support team can route an enquiry without being the party legally responsible for every claim.
- Third-order consequence
If a new product appears, retailers could compare its written support terms with those of existing Wave 2 offers. No such launch is established here.
- Fourth-order consequence
A separately documented distribution or support agreement could change the route in a named country. Do not transfer that conclusion to other sellers or territories.
- Fifth-order consequence
Only actual listings and subsequent orders could start to show commercial use of the acquired portfolio. Even then, availability would not prove broad sales or medical benefit.
Costs, benefits and assumptions
There is no disclosed price for the portfolio in the buyer release, no verified new-device price and no basis to calculate a payback period. For an owner, the immediate decision is whether another purchase is necessary at all. Check the existing order and support response before treating a replacement as an unavoidable expense.
What would change our view?
The buyer can hold or develop the IP without launching a retail product. A future official support notice could change the contact route. Silence about a warranty assignment does not prove an assignment occurred or did not occur.
Alternative explanation
A retailer, subscription provider or local distributor may hold the relevant order record. Ask the identified seller for written terms while using Embr’s named product-support route; do not assume these are the same role.
What would confirm it
For a changed support route, require current official instructions naming the model and market. For a new product, look for a dated orderable listing naming the model, seller and territory. For a particular warranty claim, seek the applicable terms and a case-specific response.
What would disprove it
A later official direction naming a different contact would supersede the current routing advice within its stated scope. A concept image, developer toolkit or strategic statement is not a product available to buy.
Evidence and sources
- Therabody, 18 Nov 2026View source
Publisher: Therabody via PR Newswire
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2026-11-18
Source retrieval date 2026-11-19
Coverage and independence
buyer’s IP acquisition announcement and Wave 2 order/support direction. Not executed instrument.
- Embr Labs, 14 Apr 2021View source
Publisher: Embr Labs via PR Newswire
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2021-04-14
Source retrieval date 2026-11-19
Coverage and independence
original Wave 2 announcement, not a 2026 launch.
- MIT News, 27 Sep 2017View source
Publisher: MIT News
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2017-09-27
Source retrieval date 2026-11-19
Coverage and independence
historical original wristband and founders, no verification of 2026 deal.
- Embr support contactView source
Publisher: Embr Labs
Original language: English
retrieved date precision: day
Source retrieval date 2026-11-19
Coverage and independence
direct route to message the team. No guarantee of individual resolution.
- Embr registrationView source
Publisher: Embr Labs
Original language: English
retrieved date precision: day
Source retrieval date 2026-11-19
Coverage and independence
direct order confirmation serves as registration; retailer purchases and gifts are directed to register. Registration helps check eligibility, not automatic coverage.
- Embr international shoppingView source
Publisher: Embr Labs
Original language: English
retrieved date precision: day
Source retrieval date 2026-11-19
Coverage and independence
retail channels can differ by location. No guarantee that a named retailer has stock or honours a particular claim.
- Embr warranty FAQView source
Publisher: Embr Labs
Original language: English
retrieved date precision: day
Source retrieval date 2026-11-19
Coverage and independence
describes a limited warranty and points readers to Terms of Sale; verify the applicable written terms with the seller.
- Embr Labs distribution announcement, 5 Jan 2023View source
Publisher: Embr Labs via PR Newswire
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2023-01-05
Source retrieval date 2026-11-19
Coverage and independence
historical retailer routes illustrate why a buyer should identify the original seller. Not proof of inventory, an active distribution contract or warranty terms today.
- Embr Labs subscription announcement, 2 Apr 2024View source
Publisher: Embr Labs via PR Newswire
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2024-04-02
Source retrieval date 2026-11-19
Coverage and independence
Embr launched a subscription then, so purchase and subscription paperwork may differ. Historical pricing and terms do not establish current offers or individually applicable rights.
- Embr Terms of Service, v2.7View source
Publisher: Embr Labs
Original language: English
retrieved date precision: day
Source retrieval date 2026-11-19
Coverage and independence
explicitly marked updated 2 Jul 2026, not first published that day. This is a dated version of terms, not evidence the 2026 acquisition transferred any particular retail warranty.
- Therabody’s own initiative launch video, 28 Jan 2025View source
Publisher: Therabody
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2025-01-28
Source retrieval date 2026-11-19
Coverage and independence
its stated priorities already included menopause. This establishes prior buyer strategy, not an Embr product launch, clinical result, consumer demand or change to support.
- Wave 2 developer tools announcementView source
Publisher: Embr Labs via PR Newswire
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2026-05-07
Source retrieval date 2026-11-19
Coverage and independence
07:00 US Eastern time. Embr announced developer tools for the existing Wave 2. No conclusion about clinical outcomes, future software maintenance or warranty coverage.
- Embr Wave 2 manual, public filing exhibit 5247966View source
Publisher: Embr Labs; public FCC filing exhibit via FCCID.io
Original language: English
published date precision: day
retrieved date precision: day
Source publication date 2021-05-15
Source retrieval date 2026-11-19
Coverage and independence
Public-record availability date: 15 May 2021; file created 13 April and submitted 14 May. The manual distinguishes device and charger model IDs. Its historical warranty wording does not settle a current claim.
Gaps in the evidence
Therabody is the source for its acquisition announcement. Historical Embr releases establish prior devices and sales channels, not current stock or contractual succession. MIT covers the original wristband, not the transaction. No transfer instrument or individual warranty determination was reviewed.
Explore the research
Research layers
Research entries
Layer name
01 Money Flow
Research and limitations
portfolio acquisition announced; consideration and settlement not established.
Layer name
02 Early Orders / Deposits
Research and limitations
no post-deal retailer order or deposit established.
Layer name
03 Bottlenecks
Research and limitations
converting IP into a saleable product is separate from buying it; no measured delay.
Layer name
04 Second / Third-Tier Beneficiaries
Research and limitations
existing owners have an identified support route; paid supplier gains unestablished.
Layer name
05 Listed Company Finances And Quote
Research and limitations
no verified transaction valuation, margin or quoted pure-play exposure.
Layer name
06 Transparent Customer Unit Economics
Research and limitations
no production cost, price, sell-through or payback evidence.
Layer name
07 Insider And Institutional Activity
Research and limitations
not assessed; no inference.
Layer name
08 Hiring
Research and limitations
no deal-specific hiring established.
Layer name
09 Public Procurement And Budgets
Research and limitations
not applicable to the disclosed private IP transaction.
Layer name
10 Foreign-Language Warning
Research and limitations
cited evidence is English; no multilingual corroboration claimed.
Layer name
11 Behaviour And Payment
Research and limitations
support direction documented, not customer satisfaction or purchase activity.
Layer name
12 Contradictory Market Readings
Research and limitations
the buyer can develop or hold IP without launching a new product.
Layer name
13 Observed Missing Expected Activity
Research and limitations
no dated launch or detailed warranty transfer in the cited announcement.
Layer name
14 Commercial Pilots And Approvals
Research and limitations
no claim of clinical efficacy, authorisation or approval of a future product.
Layer name
15 Competitive Weaknesses
Research and limitations
no market-share shift or displacement demonstrated.
Layer name
16 Cross-Border Spillovers
Research and limitations
do not generalise warranty or consumer rights across jurisdictions.
Layer name
17 Dated Prior Otr Outcomes / Failures
Research and limitations
no earlier matched outcome established; not a forecast hit.
Layer name
18 Investor Awareness / Priced-In Test
Research and limitations
no verified market-pricing or investor-awareness conclusion.
Layer name
19 Strongest Disconfirming Facts
Research and limitations
new official support instructions supersede today’s advice; a dated orderable listing establishes observed availability only for that model, seller, territory and observation date, not efficacy or past sales.
Layer name
20 Action Clock / First Proof / Money / Stop Rule
Research and limitations
check current support instructions when opening a case; recheck at any new published warranty, named product or order disclosure. Stop short of paying on the basis of the acquisition headline.
AI powered research